A distinct innate immune signature marks progression from mild to severe COVID-19

Published: 15 December 2020| Version 1 | DOI: 10.17632/vyy8ttw7n9.1
Stephane Chevrier,
Yves Zurbuchen,
Carlo Cervia


Mass cytometry and Olink data generated in the context of the characterization of the innate immune response to SARS-CoV-2 infection in a cohort of 70 covid-19 patients and 22 healthy individual collected in 4 hospital in Zürich (Switzerland) in spring 2020.